Several previous linkage scans in type 2 diabetes (T2D) families indicated a putative susceptibility locus on chromosome 12q15 -q22, while the underlying gene for T2D has not yet been identified. We performed a region-wide association analysis on 12q15 -q22, using a dense set of >500 single-nucleotide polymorphisms (SNPs), in 1492 unrelated Japanese individuals enrolled in this study. We identified an association between T2D and a haplotype block spanning 13.6 kb of genomic DNA that includes the entire SOCS2 gene. Evolutionary-based haplotype analysis of haplotype-tagging SNPs followed by a ''sliding window'' haplotypic analysis indicated SNPs that mapped to the 5V region of the SOCS2gene to be associated with T2D with high statistical significance. The SOCS2 gene was expressed ubiquitously in human and murine tissues, including pancreatic h-cell lines. Adenovirus-mediated expression of the SOCS2 gene in MIN6 cells or isolated rat islets significantly suppressed glucosestimulated insulin secretion. Our data indicate that SOCS2 may play a role in susceptibility to T2D in the Japanese. D 2005 Elsevier Inc. All rights reserved.
Type 2 diabetes (T2D) is a complex group of disorders characterized by two distinct pathophysiological defectsimpaired insulin secretion from pancreatic h cells and insulin resistance in muscle, fat, and the liver [1] . While genetic factors are known to affect both of these components [2] , the search for the susceptibility gene(s) has proven to be a challenge. at least two common genetic variants accounting for a substantial proportion of common T2D: the Pro12Ala variant of the peroxisome proliferative activated receptor, gamma (PPARG) and the Glu23Lys variant of the potassium inwardlyrectifying channel, subfamily J, member 11 (KCNJ11) (for a review, see [3] ). These variants may contribute significantly to the risk of T2D, conferring insulin resistance on hepatic, muscle, and fat tissues (PPARG, Pro12Ala) and a relative insulin secretory deficiency (KCNJ11, Glu23Lys). Associations between each variant and T2D were tested in different racial and ethnic groups and widely reproduced with modest estimated odds ratios (ORs) of 1.2-1.5. Such studies of candidate genes are, however, largely limited to genes coding for proteins involved in known glucose homeostasis. In contrast, genomewide linkage scans for T2D should not presume any prior knowledge of the mechanisms underlying glucose/insulin regulation. To date, multiple studies in different racial groups have been performed and a number of possible susceptibility loci for both T2D and T2D-related traits were identified throughout the genome. However, only the NIDDM1 locus on chromosome 2q has been mapped to a single gene, calpain 10 [4] . As in many other cases of common multifactorial diseases, phenotypic variability and polygenic inheritance in T2D seem to be adverse factors that complicate and reduce the power of linkage analysis.
The case of the hepatocyte nuclear factor 4, alpha (HNF4A) gene is complicated but raises many interesting possibilities. The HNF4A is a transcription factor important for the development, differentiation, and function of pancreatic h cells (for a review, see [5] ). Initially, mutations in the HNF4A gene were identified as a cause of MODY1 (maturity-onset diabetes of the young, type 1), an early onset monogenic subtype of diabetes [6] . A number of T2D linkage studies, on the other hand, found evidence of linkage to 20q12 -q13.1 [7] , where the HNF4A gene is located. Taken together, these observations make HNF4A an excellent functional and positional candidate for T2D. Recent studies have found an association between T2D and four common single-nucleotide polymorphisms (SNPs) in the P2 promoter region, which lies 45 kb upstream of the liverspecific promoter and is the primary transcription start site in the h cell [8, 9] . Of these, SNP rs2144908 demonstrated the strongest, though marginal, association with T2D, with ORs of 1.33 (95% CI 1.06 -1.65) in a Finnish population and 1.46 (1.12 -1.91) in an Ashkenazi Jewish population. Of note, in both studies, the risk haplotype was thought to explain a large proportion of the evidence of linkage to 20q12-q13.1.
Genome-wide SNP association studies using genotypes of numerous samples with hundreds of thousands of SNPs and the use of linkage disequilibrium (LD) and haplotype-association mapping have been proposed as a powerful and promising approach to the identification of genes with small effects, often seen in complex traits. In fact, such strategies are beginning to reveal novel and complex disease-related genes, e.g., for myocardial infarction and rheumatoid arthritis [10 -12] . However, further development of cost-efficient SNP genotyping and characterization of the haplotype structure of the human genome are also needed. For some time, fine-scale LD and association mapping of susceptibility candidate loci identified by linkage studies could be an effective intermediate technique for identifying T2D genes. Such candidate loci, showing strong evidence of being replicated linkage signals for T2D, include chromosomes 12q [13] , 1q [14 -16] , 8p [17] , and 3q [18] . In this study, we performed a region-wide analysis of an association study for T2D with a dense set of >500 SNPs on a 27-Mb region of chromosome 12, using 1492 unrelated Japanese individuals. Our approach, which included identification of the susceptibility LD block followed by evolutionarybased haplotype analysis of haplotype-tagging SNPs (htSNPs), was useful in demonstrating an association between T2D and the suppressor of cytokine signaling 2 (SOCS2) gene.
Results

Selection of SNPs
To identify the T2D susceptibility gene on human chromosome 12q, we first examined the results of published linkage studies [16,19 -22] and found that linkage peaks on chromosome 12q were quite broad and relatively confusing. At least two separate 12q regions have been identified with supportive evidence, one near the NIDDM2/MODY3 locus (in 12qter) and the other more centromeric (12q15 -q22). In this study, we decided to target the 12q15-q22 region. Our target region corresponded to a 27-Mb interval between two STS markers, D12S375 and D12S362, which encompasses the 1-LOD-drop support interval of linkage signals, extending from 80 to 100 cM on chromosome 12 when adjusted for the positions of genetic markers using the Marshfield Genetic Map as a reference. The region thus included neither the linkage signals identified as the NIDDM2locus by Mahtani et al. [23] nor signals identified by Shaw et al. [24] in their Australian pedigree. Our target region included a total of 125 genes based on the National Center for Biotechnology Information (NCBI) Build 34 human genome assembly. We subsequently searched for SNP markers within the region with the following criteria: (1) suitability for designing optimal TaqMan high-throughput genotyping [25] ; (2) mapping to the gene-centric region, which we assigned to an interval between 10 kb upstream of the transcription start site and 10 kb downstream of the final exon; (3) an average distance of 10 kb between adjacent SNPs whenever possible; and (4) common SNPs with a minor allele frequency (MAF) >0.15 based on the genotype data of 46 Japanese control individuals supplied by Applied Biosystems (unpublished data).
We initially obtained a total of 652 TaqMan genotyping probes from Applied Biosystems and genotyped an additional 111 Japanese control individuals to assess the genotyping quality (a total of 157 ''genotyping and quality'' controls, combining 46 and 111 individuals). After excluding SNPs with ambiguous genotyping qualities, those with significant deviations from the Hardy -Weinberg equilibrium ( p value <0.05, m 2 test) or with MAF <0.10, a total of 585 SNPs were selected as the GeneCentric, Evenly Spaced Common SNPs and used for further association testing (a complete list of SNPs is available in Appendix A1 and a statistical summary is shown in Appendix A2; appendices are in the supplementary material). Of these, 536 SNPs (91.6%) were mapped within 91 genes (72.8% of the total target genes), with an average distance of 12.5 kb, and 49 were in intergenic regions. The average MAF of the 585 SNPs was 0.34 T 0.11 (SD). There were a significant number of allelic associations among the SNPs, mostly between two or three adjacent SNPs (data not shown). When SNP haplotype blocks were generated by the LD-based algorithm of Gabriel et al. [26] , we identified 129 independent SNP haplotype blocks.
Association study
To reduce the time and cost of genotyping, we designed a large, modified two-stage case -control association analysis in the 1492 unrelated Japanese individuals with the 585 GeneCentric, Evenly Spaced Common SNPs on chromosome 12q (Appendix B provides an overview of the study design).
In Stage 1 (Discovery panel), we genotyped 147 Japanese individuals with T2D at all 585 SNP loci and compared allelic frequencies with those of 157 genotyping and quality controls (see above), using a standard m 2 test. In Stage 1, we selected SNP markers with a relatively high significance level of a < 0.10 to increase statistical power for detecting associations. This also meant most of the SNPs selected at this stage were likely to be false positives. Thirty-seven SNPs were selected in Stage 1 (Appendix A1). We noticed that the number of SNPs selected was fewer than expected (see below), and this was probably due to the presence of marker -marker associations among SNPs. For the 37 SNPs selected in Stage 1, we genotyped an additional 259 control and 188 T2D individuals, pooled genotypic data, and regarded this expanded panel as Stage 1E (Expanded panel; a total of 416 control and 335 T2D individuals). We chose a significance level of a < 0.05 in this pooled Stage 1E and selected 9 of 37 SNPs (SNP017, SNP152, SNP260, SNP262, SNP378, SNP380, SNP488, SNP489, and SNP514).
Next, we tested the nine SNPs selected in Stage 2, an independent replicative panel consisting of 376 T2D subjects and 365 control subjects, with an increased significance level of a < 0.01 (Table 1) . Overall, our two-stage, step-wise focusing design was expected to select less than one falsepositive SNP on average (since 585 SNPs were initially tested, average numbers of false-positive markers were expected to be 59 in Stage 1 (585 SNPs at a = 0.1), 30 in Stage 1E (585 SNPs at a = 0.05), and 0.3 in Stage 2 (30 SNPs at a = 0.01), without taking account of allelic associations). In Stage 2, only a single SNP, SNP488 (rs10777530), marginally reached the significance level ( p = 0.0095, Table 1 ). A retrospective analysis of the power for the significant association detected revealed that the probabilities for detecting the differences between cases and controls for SNP488 were 55.5% at Stage 1 (significance level a = 0.1), 79.6% at Stage 1E (a = 0.05), and 58.2% at Stage 2 (a = 0.01).
When all of the genotypic data were pooled (Stages 1E and 2, a total of 781 controls and 711 T2D individuals), the crude OR for SNP488 was 1.32 (95% CI 1.15-1.53, p = 0.00013). Logistic regression analysis revealed that the association between SNP488 and T2D remained statistically significant after adjustment for age and sex (data not shown). It should be mentioned that, when Bonferroni_s correction for multiple analyses was applied for 585 independent tests (number of initial SNPs), SNP488 did not reach statistical significance (Bonferroni-corrected p = 0.076). However, because significant LD existed in our 585 SNPs, such that they were not completely ''independent,'' Bonferroni_s correction was likely to be too conservative. It is noteworthy that, in the pooled data set, two other SNPs, SNP489 (rs10745657) and SNP152 (rs7137054), were significantly associated ( p < 0.05) with T2D (SNP489, OR 1.28, 95% CI 1.10 -1.50, p = 0.0019; SNP152, OR 1.20, 95% CI 1.04-1.39, p = 0.01). We could not exclude the possibility of the associations for SNP489 and SNP152 being false positives; however, because SNP489 was close to SNP488 and these two SNPs were in strong LD (|DV| = 1.00), we assumed both to be associated with the same putative susceptibility variant(s).
To determine the probability that our significant associations were false positives, we applied the false positive report probability (FPRP) method that was recently proposed by Wacholder and colleagues [27] . The FPRP is determined by:
(1) the prior probability of a true association, (2) observed p value for the association, and (3) statistical power of the study. Since the current study was the hypothesis-driven candidate region scan, we assigned a low to moderate prior probability range (0.1 to 1%). To determine FPRP values, we used our experimentally determined values of OR and the corresponding 95% CI for SNP488, SNP489, and SNP152 in the total study group. For a prior probability of 0.1%, we obtained the FPRP value of 0.193 for SNP488, which satisfied a stringent FPRP value of <0.2 [27] and indicated our findings to be noteworthy (0.701 for SNP488 and 0.938 for SNP152). For a prior probability of 1%, the FPRP value for SNP488 was less than 5% (0.023). In addition, the FPRP value for SNP489 (0.188) was also satisfied at a <0.2 FPRP level (the results of FPRP analysis are summarized in Appendix C). As a result, our association test identified two associated SNPs, SNP488 and SNP489, as putative candidate SNPs for Japanese T2D. The results are summarized in Table 1 and illustrated graphically in Fig. 1 .
Determination of LD block structure around SNP488 -SNP489
SNP488 and SNP489 were mapped to the 5V and 3V regions of the SOCS2 gene, respectively, with a distance of 12,391 bp. There was strong LD between the two (|DV| = 1.00), indicating that both SNPs are in the same LD block. Since the length of the LD block may have extended beyond 12 kb, and therefore might contain a gene(s) other than SOCS2, and to investigate the LD structure in detail and to clarify the susceptibility region, we again searched various databases for ungenotyped SNP markers flanking SNP488 and SNP489. We identified four new SNPs (ZS003, SNP487, A356, and A357) in the public database and genotyped them in all DNA panels (Stage 1E and Stage 2), along with SNP490 used in Stage 1. LD analysis using these seven SNPs indicated that SNP488, A356, and SNP489 belonged to the same LD groups (|DV| > 0.99), while four other SNPs clearly lay outside the haplotype block (ZS003 -SNP487 in the upstream region and A357 -SNP490 in the downstream region; see Appendix D).
We next conducted resequencing analysis in the¨20-kb interval between SNP487 and SNP490 to search for unidentified SNPs and to determine the exact boundaries of a given haplotype block. For this purpose, we chose genomic DNAs from 24 control individuals for direct sequencing analysis and identified 50 new polymorphic sites (49 SNPs and 1 microsatellite, data not shown). We genotyped all DNA panels (Stage 1E and Stage 2), and the subsequent LD analysis using SNPs with MAF > 0.1 using the Haploview software [28] identified three haplotype blocks (Fig. 2) . A putative T2D susceptibility LD block as defined by Gabriel_s rule [26] spanned a 13,584-bp genomic region between the ZS009 and the SNP489 markers (Fig. 2 , Fig. 1 . Results of SNP association study on chromosome 12q. Gene-centric, evenly spaced common SNPs on chromosome 12q15 -q22 are shown with p values for the association test. For Stages 1, 1E, and 2, 585, 37, and 9 SNPs were analyzed, respectively. The target chromosomal region for the association study is shown above. Gene-centric regions (black boxes) of 128 genes are shown in the middle. Note that SNPs were selected mainly in gene-centric regions (average SNP distance, 12.5 kb) rather than in the intergenic regions.
Block 2). There were 34 polymorphic sites within Block 2 in the Japanese population (Table 2 ), including one rare synonymous coding SNP in exon 3 (ZS006; Y268Y) and two SNPs in the 5V untranslated region of the SOCS2 gene. We also confirmed that SOCS2 was the only gene that mapped within Block 2.
SNP haplotypes, cladistic analysis, ''sliding window'' analysis Results of association tests for the 34 polymorphic sites in Block 2 are shown in Table 2 . We observed significant associations with all common SNPs of MAF > 0.25 and a microsatellite MS1, but not with rare SNPs. The most significantly associated SNP was ZS011 (rs12425869, p = 0.000063), which was adjacent to and in complete LD (r 2 = 1) with SNP488.
To identify the putative susceptibility site(s) responsible for the observed association in Block 2, we applied a cladistic approach proposed by Templeton et al. [29] . This approach allows analysis of multilocus data within a genomic segment/ gene by considering haplotypes and grouping them in nested clades. The idea is to search for clades with an association between haplotypes and phenotypes and to identify the mutations defining these clades as potential candidate disease susceptibility sites. For the analysis, we first estimated haplotype frequencies of 22 SNPs in Block 2 that were relatively common in terms of their frequencies (MAF > 5%) using SNPAlyze _ v.3.2.1PRO software, which is based on the Expectation -Maximization (EM) algorithm. Five major haplotypes that covered more than 97% of all haplotypes were observed (data not shown). The SNPtagger program [30] then revealed that these five haplotypes (Nos. 1-5) were tagged (or identified) by four htSNPs, ZS009, ZS012, ZS004, and ZS016. We found a significant association with T2D by the haplotype association analysis using the four htSNPs and identified a common disease-protective haplotype 1 (Table 3 , permutation p = 0.00051) and an at-risk haplotype 2 (permutation p = 0.00097). Finally, a cladistic-based association analysis was performed using the Evolutionary-Based Haplotype Analysis Package (EHAP) _ v1.1 program [31] . Results showed that all five haplotypes were connected in a cladogram according to their evolutionary history (Table 3 ). In addition, the diseaseprotective haplotype (1) could be discriminated from other haplotype groups (2, 3, 4, and 5, score test p = 0.0001). Because a single mutational step at htSNP ZS009 was responsible for this observation, we concluded that ZS009 was most likely to be etiologically associated with the diseasesusceptibility variant.
The htSNP ZS009 represents 17 polymorphic sites within Block 2 (Table 2) . However, further application of a conventional fine-mapping strategy appeared to be limited because these 17 SNPs were highly correlated with one another (r 2 > 0.8, data not shown) and showed similar results in single-locus association tests at their loci (Table 2) . To obtain the best partition of haplotypes associated with T2D, we employed a sliding window analysis using the HTR program [32] , which compares, in cases and controls, the frequencies of haplotypes generated with a specified number (window size) of contiguous markers. We assumed that the sliding window approach might better localize the region encompassing disease-susceptibility variants since it would give a quantitative idea of the signal observed in the ''background.'' As shown in Fig. 3 , results with window sizes of 2 (two-locus) and 3 (three-locus) clearly indicated SNPs in the 5V region of the SOCS2 gene to be associated with an increased risk for T2D with high statistical significance. The strongest association was observed with a pair of SNPs, ZS011 -ZS013 ( p = 0.000035, two-locus) and a trio of SNPs ZS011 -ZS013 -ZS014 ( p = 0.000019, threelocus). We tested with window sizes up to 6 and the results were essentially the same (data not shown). SNPs ZS011, ZS013, and ZS014, together with two additional SNPs (ZS010 and SNP488), were in perfect LD with each other (r 2 = 1), locating within a 2955-bp genomic segment that included noncoding exon 1 and the 5V flanking region of the SOCS2 gene. The locations of the SNPs relative to the putative SOCS2 transcription start site were as follows: S010, À2681 bp; SNP488, À2488 bp; ZS011, À2245 bp; ZS013, À639 bp; ZS014, +274 bp. Frequencies of the at-risk haplotype (ZS010-SNP488-ZS011-ZS013-ZS014, G-C-A-T-C) and protective haplotype (C-T-G-C-T) were 0.481 and 0.519 in controls and 0.552 and 0.448 in T2D, respectively. The at-risk haplotype was associated with T2D and the association was statistically significant even after adjusting the regression for age and gender (crude OR 1.33, 95% CI 1.08 -1.63, p = 8.8 Â 10 À5 , adjusted OR 1.37, 95% CI 1.14-1.66, p = 0.00098).
Based on our observations, we concluded that these five SNPs in the regulatory region of the SOCS2 gene are promising candidates for T2D susceptibility markers in the Japanese population.
Association study of SOCS1 and SOCS3 genes SOCS2 belongs to the SOCS gene family, which has at least eight members (SOCS1 -7 and CIS) [33] . Among SOCS proteins, SOCS1 and SOCS3 are known to be natural inhibitors of cytokine signaling and also to influence insulin signaling (for a review, see [34] ). Therefore, in addition to the SOCS2 gene, we speculated that SOCS1 and SOCS3 genes might also be good candidates for involvement in the development of both T1D and T2D. In fact, Gylvin et al. [35] previously searched for SOCS3 mutations in Danish subjects and reported an association between homozygosity for a À920 C-A promoter polymorphism and increased whole-body insulin sensitivity in young healthy unrelated individuals. To test this hypothesis in Japanese subjects, we selected SNPs in the SOCS1 (SNP SC003, 004, 005, and 006) and SOCS3 (SNP S3C01, 11, 08, 02, 13, 09, 10, 12, 04) genes, based on our Gene-Centric, Evenly Spaced Common SNPs criteria (see Selection of SNPs) and tested for association in our population (information on SNPs and results of the association study are provided in Appendix E). No significant differences in allelic frequencies of the SNPs between cases and controls were detected, suggesting that neither the SOCS1 nor the SOCS3 gene plays a major role in conferring increased susceptibility to T2D in our population.
Expression and functional testing of the SOCS2 gene product
We analyzed the levels of SOCS2 mRNA expression in different human and mouse tissues and cell lines (Fig. 4) . In adult human tissues, a clear differential expression of SOCS1 - 3 mRNAs was noted (Fig. 4A) . SOCS2 expression was high in the prostate and uterus and relatively low in insulin target tissues such as the liver, skeletal muscle, and adipose. SOCS1 was more abundantly expressed, with relatively high levels in many other tissues, such as the lung, prostate, uterus, and placenta. SOCS3 expression was high in adipose, lung, and aortic tissues. In mice, Socs2 expression was again relatively low in peripheral tissues such as fat, compared to the brain (Fig. 4B) . Although we tested only a limited number of cell lines, pancreatic h-cell lines (MIN6, NIT1) apparently expressed relatively high levels of Socs2 (Fig. 4C) .
Because expression data suggest no immediate functional relevance of the SOCS2 gene in diabetes pathophysiology, we conducted functional screens using an adenovirus-mediated SOCS2 overexpression system. First, glucose-induced insulin secretion was evaluated by overexpressing SOCS2 in MIN6 or isolated rat islets (Figs. 5A and 5B). Interestingly, SOCS2 overexpression resulted in significantly decreased glucosestimulated insulin secretion in both MIN6 (Fig. 5B , Ad-SOCS2 vs control, 72.9 T 2.7 vs 94.7 T 4.0 ng ml À1 , n = 3, p < 0.001) and islets (20.5 T 2.1 vs 25.9 T 1.9 ng ml À1 , n = 5, p = 0.003). It is noteworthy that, even in untreated MIN6 cell extracts, endogenous SOCS2 protein was detectable using standard Western blot techniques (Fig. 5A, lane.1 ), confirming our SOCS2 expression results. We also tested whether overexpressing SOCS2 in 3T3-L1 adipocytes affects glucose uptake in response to insulin stimulation; however, no significant difference was observed (data not shown).
Discussion
The current study was designed to determine whether the gene(s) located on chromosome 12q is associated with susceptibility to T2D in the Japanese population. It should be mentioned that, in the Japanese, no linkage study has identified chromosome 12q as a definitive region conferring susceptibility to T2D. However, we hypothesized that the T2D susceptibility gene is likely to be shared among different racial groups, as seen with the PPARG and KCNJ11 genes. When the study was initiated in 2001, there were several uncertainties regarding the accuracy and influencing factors for haplotype inference in random population samples using the EM algorithm, which were later extensively investigated in simulation models and with actual haplotype data [36 -38] . Therefore, in this study, we focused on the gene-coding regions on 12q15 -q22 and chose SNPs yielding priorities in their locations and allele frequencies, rather than relying on LD information. Recently, Phase I and II results of the International HapMap Project, with the increased density of the map to one SNP every kilobase, became available [39, 40] . It is now hoped that these results will facilitate the identification of the haplotype blocks and the common haplotypes in the human genome and the definition of an optimum set of tag SNPs for more cost-effective large-scale genetic association studies.
Our results indicate, for the first time, that the SOCS2 gene is a potential candidate gene for T2D. SNPs significantly associated with Japanese T2D (best SNP: ZS011 (rs12425869), p = 6.3 Â 10 À5 ) were located within a 13,584-bp block of LD (Block 2) that contained the entire SOCS2 gene region. We identified 34 polymorphic sites within Block 2; however, none of these SNPs were predicted to effect amino acid change. Interestingly, a sliding window method of haplotype analysis indicated SNPs mapped to the 5V region of the SOCS2 gene to be associated with T2D with a high statistical significance. These findings prompted us to speculate that nucleotide changes in the regulatory region of the SOCS2 gene might lead to functional consequences in terms of SOCS2 gene expression and alter susceptibility to T2D. However, a search for potential transcription factor binding motifs in the SNP sites revealed no such motif (TRANSFAC database [41] , data not shown). Promoter reporter gene assays using luciferase reporter gene constructs containing the at-risk haplotype (ZS010 -SNP488 -ZS011 -ZS013 -ZS014, G-C-A-T-C) are under way in our laboratory, but we have not yet observed any obvious changes in HEK293 or HeLa cells (data not shown). Since an effect on gene function is likely to be small in common disorders like T2D, it is possible that our artificial assay system may not be sensitive enough to detect and assess such subtle effects of SNPs.
The SOCS2 gene product is a member of the SOCS family, which has at least eight members (SOCS1 -7 and CIS, the cytokine-inducible SH2 domain-containing protein). It has been suggested that SOCS family proteins participate in negative feedback loops in cytokine and growth factor signaling via multiple distinct mechanisms [42, 43] . Among the SOCS proteins, SOCS1 and SOCS3 in insulin-sensitive tissues have been shown to increase in insulin-resistant states, such as obesity and endotoxemia. They were also shown to attenuate insulin signaling by binding to the insulin receptor (IR) and inhibiting phosphorylation of insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) [44] . To date, no in vitro experimental data indicating an association between SOCS2 protein and IR signaling have been obtained. SOCS2 protein instead acts as a negative regulator of the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) signaling pathways [45, 46] . SOCS2 has been shown to bind to the GH receptor and inhibit GH signaling by multiple mechanisms, for example by attenuating STAT5 activation. Socs2 knockout mice exhibit gigantism characterized by increased body weight and length [47] , though neither T2D nor diabetes-related phenotypes were reported in these mice. Importantly, the GH/ IGF-1 axes are known to be important mitogenic signal transduction pathways in h cells [48] . Pancreatic h cells express both GH and IGF-1 receptors [49] . GH has been shown to stimulate insulin gene transcription, biosynthesis, and secretion and to increase h-cell proliferation. In mice, GH receptor gene deficiency (GHR À/À ) resulted in elevated insulin sensitivity and diminished pancreatic islet cell mass and serum insulin levels [50] . Mice lacking both IGF-I receptors and IRS-2 show a marked reduction of h-cell mass and die from diabetes due to h-cell insufficiency [51] , indicating that IGF-1 receptors couple to IRS-2 in pancreatic islets to mediate h-cell development, proliferation, and survival. From these observations, the dysregulation of SOCS2 might potentially attenuate GH and/or IGF-1 signaling in h cells and thereby lead to loss of h-cell mass and diabetes. Of note, our preliminary experiments with adenoviral-mediated overexpression of SOCS2 in MIN6 cells or isolated rat islets showed a 25% suppression of glucose-stimulated insulin secretion. This suggests that increased SOCS2 protein in h cells impairs insulin biosynthesis/storage or glucose sensing, although the exact cellular mechanism is not known at present.
In summary, in the current study, we identified SOCS2 as a new candidate gene for T2D in the Japanese population. We also obtained detailed information about polymorphic DNA sites and haplotype divergence in the SOCS2 gene region. Although we carefully designed the study protocol to minimize both false positive and false negative association results, this study was no more than a single population-based case -control study. Therefore, replication studies in other independent populations, especially in those in which linkage has been reported, or family-based tests of association are priorities for determining the consistency of our observations. Obviously, future assessment of a quantitative effect of the associated haplotypes on phenotypes will greatly facilitate understanding the physiology. The function and mechanism of SOCS2 action in pancreatic h cells also need to be elucidated. 
Materials and methods
Subjects
The study was conducted in accordance with the tenets of the Declaration of Helsinki. All subjects consented to participate in this study in accordance with the process approved by the Ethical Committee for Human Genome and Gene Research at the University of Tokushima. A total of 711 Japanese individuals with T2D (47.3% women; mean age 62.6 T 11.4 (SD) years; mean BMI 23.7 T 3.40 (SD)) and 781 control individuals (54.9% women; mean age 40.6 T 16.3 (SD) years; mean BMI 22.0 T 3.05 (SD)) were recruited mainly from the Eye Clinic at Tokushima University Hospital and Kyoto Prefectural University Hospital and its affiliates. The diagnosis of T2D was made either by the 1985 WHO criteria [52] or by being treated with medications for diabetes. Genomic DNA samples were extracted from peripheral blood leukocytes or EB virusimmortalized B lymphoblasts according to a standard method. Some genomic DNA samples were amplified prior to genotyping using the GenomiPhi DNA Amplification Kit (Amersham Biosciences, Uppsala, Sweden).
SNP genotyping
Most SNPs were genotyped by TaqMan assays [25] according to the manufacturer_s protocol with modifications, using commercially available reagents (TaqMan Universal PCR Mastermix, No UNG, TaqMan SNP Genotyping Assays, Custom TaqMan SNP Genotyping Assays; Applied Biosystems, Foster City, CA, USA). Our success rate for allele-calling in the Stage 1 study was 99.86% (=177,595/177,840 genotypes, 585 SNPs Â 304 subjects). Genotyping accuracy was assessed as follows: 30 SNPs were randomly chosen and genotypes of 32 subjects were determined by direct sequencing analysis and compared with the results of TaqMan assays. Genotype concordance between the two genotyping methods was 100% (959/959 genotypes, a single assay resulted in an ''undetermined'' genotype and was excluded from the calculation).
In the case of SNPs being problematic in designing TaqMan probes or optimizing assays, PCR allele-specific primer (PCR-ASP) assays [53] or direct sequencing assays were used for genotyping. In PCR-ASP assays, the amount of PCR product amplified with allele-specific primers was monitored using the ABI Prism 7900HT sequence detection system (Applied Biosystems) with fluorescent double-strand DNA binding dye (SYBR Green PCR Master Mix; Applied Biosystems). Genotypes were identified by comparing the amount of each allele-specific amplicon. For the PCR direct sequencing analysis, PCR amplicons (averaging 500 -600 bases in length) were sequenced directly from both sense and antisense ends with an ABI Prism BigDye Terminator Cycle Sequencing-Ready Reaction Kit (version 1.1 or 3.1; Applied Biosystems) using automated sequencers (ABI Prism 3100 genetic analyzer and Applied Biosystems 3730xl DNA analyzer; Applied Biosystems). One microsatellite (MS1) was genotyped by electrophoresing the fluorescence-labeled PCR amplicons with an automated sequencer (Applied Biosystems 3730xl DNA analyzer; Applied Biosystems) followed by analysis using GeneMapper _ v3.0 (Applied Biosystems).
Genetic computer software
Computer software programs used in this study were as follows: (1) [55] . In the present study, we calculated empirical p values by using permutation tests for 1,000,000 replicates. (4) HTR (http://statgen.ncsu.edu/zaykin/htr.html): the HTR program estimates haplotype frequencies using the EM algorithm and then relates the inferred haplotype frequencies to the observed phenotype using a regression model [32] . In the present study, we calculated empirical p values by using permutation tests for 1,000,000 replicates. The HTR also provides a sliding window mode of haplotype association analysis, which compares, in cases and controls, the frequencies of haplotypes generated with a specified number (window size) of contiguous markers. (5) [29] . The EHAP utilizes information contained in the evolutionary relationships among haplotypes and in the sample using generalized linear models. A sequential test series is performed first considering haplotypes that fall into the external nodes of the cladogram (zero-step clades) and then considering one-step clades (produced by moving backward one mutational step from the zero-step clades toward internal nodes), two-step clades, and so forth. From an ancestral haplotype, polymorphisms lead to the observed diversity of haplotypes, which is summarized in a cladogram. By assessing the distribution of phenotypes within a cladogram, it is possible to search for the putative causal polymorphism (mutation) with an increased statistical power. [27] . The FPRP requires prior estimation of the probability that a gene is associated with the phenotype and is compatible with the Bayesian view that the prior credibility of the hypothesis should influence evaluation of association studies. To obtain FPRP values, the estimated prior probability range, the statistical power to detect an OR of 1.5, and observed ORs and 95% confident intervals were entered into the calculation sheet provided by Wacholder et al. [27] .
Expression analyses
Quantitative RT-PCR analyses to estimate the expression of human and mouse SOCS1 -3 were performed using an ABI Prism 7900 sequence detection system (Applied Biosystems) with SYBR Green PCR Master Mix (Applied Biosystems), following the manufacturer_s instructions. The primers for detecting mRNA of human SOCS1 -3 were SOCS1 (NCBI Reference Sequence NM _ 003745), hSOCS1F, 5V-TAGCACACAACCAGGTGGCA-3V, and hSOCS1R, 5V-GCTCTGCTGCTGTGGAGACTG-3V; SOCS2 (NM _ 003877), hSOCS2F, 5V-CCTTTATCTGACCAAACCGCTCTA-3V, and hSOCS2R, 5V-TGTTAATGGTGAGCCTACAGAGATG-3V; SOCS3 (NM _ 003955), hSOCS3F, 5V-TCTCTGTCGGAAGACCGTCAA-3V, and hSOCS3R, 5V-CGGCAGCTGGGTGACTTT-3V. The primers for detecting mouse Socs1 -3 mRNAs were Socs1 (NM _ 009896), mSOCS1F, 5V-GGCACCTTC-TTGGTGCGC-3V, and mSOCS1R, 5V-AAGCCATCTTCACGCTGAGC-3V; Socs2 (NM _ 007706), mSOCS2F, 5V-ATATCCGTTAAGACGTCAGCTGG-3V, and mSOCS2R, 5V-TATGATAGAATCCAATCTGAATTTCCC-3V; Socs3 (NM _ 007707), mSOCS3F, 5V-CAAGACCTTCAGCTCCAAAAGC-3V, and mSOCS3R, 5V-CTCCAGTAGAATCCGCTCTCCT-3V. SOCS1 -3 gene expres-sion was normalized with the expression of G3PDH for human and h-actin for mouse mRNA. The primer pairs used for human G3PDH and mouse h-actin were hG3PDH-F, 5V-GGGAAGGTGAAGGTCGGA-3V, and hG3PDH-R, 5V-GCAGCCCTGGTGACCAG-3V; mh-actinF, 5V-TCTGTGTGGATCGGTGGC-3V, and mh-actinR, 5V-GCTGATCCACATCTGCTGGA-3V. All oligonucleotides were purchased from ProOligo (Lismore, NSW, Australia).
Total RNA was extracted from the pancreas of C57BL/6 mice and various cell lines (L1, NIT1, and MIN6), using the RNeasy kit (Qiagen N.V., Venlo, The Netherlands) or Isogen reagents (Nippongene, Toyama, Japan). Total RNA was reverse-transcribed using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and random hexamer primers to generate first-strand cDNA. Human cDNA was purchased from BD Biosciences Clontech (Palo Alto, CA, USA) or the Biochain Institute (Hayward, CA, USA).
Adenovirus construction
Adenoviruses containing mouse Socs2 were constructed as previously described [58] . Full-length mouse Socs2 cDNAs were generated by RT-PCR with forward primer 5V-CGGGGTACCGCCATGACCCTGCGGTGCCTG-GAGCCCTCC-3V and reverse primer 5V-CCGCTCGAGTTATACCTGGAATT-TATATTCTTCCAA-3V; the KpnI and XhoI sites included in these primers are underlined. The cDNA fragment was then inserted into the KpnI -XhoI site of the pAdTrack-CMV vector [58] , and the adenoviruses were replicated and amplified in HEK293 cells.
Adenovirus-mediated overexpression of SOCS2in MIN6 cells or rat islets was achieved as previously described [59] , with concentrations of 10 8 pfu/ml for MIN6 cells and 10 6 pfu/ml for islets. For Western blotting, the MIN6 cell lysate was boiled in the SDS sample buffer with 10 mM dithiothreitol and then applied to SDS -PAGE and transferred onto to a polyvinylidene difluoride membrane (Immun-Blot PVDF Membrane; Bio-Rad Laboratories, Hercules, CA, USA). The membrane was incubated with primary anti-SOCS2 antibody (AnaSpec, Inc., San Jose, CA, USA) and thereafter with horseradish peroxidase-conjugated secondary antibody.
Glucose-induced insulin secretion test in MIN6 and isolated rat islets
The mouse insulinoma cell line MIN6 [60] was grown in DMEM containing 15% (v/v) heat-inactivated fetal calf serum (Invitrogen), 100 IU ml À1 penicillin, and 100 mg ml À1 streptomycin. Cells were cultured in a humidified atmosphere with 5% CO 2 at 37-C. Pancreatic islets were isolated from 6-to 8-week-old fed Wistar rats (CLEA Japan, Inc., Tokyo, Japan) by collagenase digestion in conjunction with Ficoll gradient separation. Islets were hand-picked under the microscope and cultured overnight in RPMI 1640 medium containing 10% (v/v) heat-inactivated fetal calf serum (Invitrogen). For glucose-induced insulin secretion testing, MIN6 cells or isolated rat islets were washed in Krebs -Ringer bicarbonate (KRB) buffer supplemented with 2.8 mM glucose, 0.1% BSA, and 10 mM Hepes (pH 7.4) in 24-well dishes. Cells and islets were then preincubated at 37-C for 1 h and further incubated for 20 min (MIN6) or 1.5 h (islets) in the KRB buffer containing 2.8 or 16.8 mM glucose. Insulin concentrations in the medium were determined with an insulin radioimmunoassay kit (Amersham Biosciences, Buckinghamshire, England) using rat insulin as a standard. All data are presented as means T SE. Student_s t test was used to determine the significance of differences between groups.
